Advertisement

Ads Placeholder
Loading...

Mallinckrodt plc

MCD.DE•XETRA
Healthcare
Drug Manufacturers - Specialty & Generic
€0.18
€-0.61(-77.34%)
German Market opens in 1h 37m

Mallinckrodt plc (MCD.DE) Stock Overview

Explore Mallinckrodt plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio-0.02
EPS (TTM)$-7.84
ROE-1.69%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

MCD.DE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Mallinckrodt plc (MCD.DE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.02 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
N/A
All-Time (Max) Change
N/A

Contact Information

https://www.mallinckrodt.com
353 1 696 0000
College Business & Technology Park, Dublin, NaN, 15

Company Facts

30,720 Employees
IPO DateFeb 1, 2022
CountryIE

Frequently Asked Questions